Are streptokinase antibodies clinically important?
作者信息
Buchalter M B
出版信息
Br Heart J. 1993 Aug;70(2):101-2. doi: 10.1136/hrt.70.2.101.
Abstract
摘要
相似文献
1
Are streptokinase antibodies clinically important?链激酶抗体在临床上重要吗？
Br Heart J. 1993 Aug;70(2):101-2. doi: 10.1136/hrt.70.2.101.
2
Streptokinase resistance: when might streptokinase administration be ineffective?链激酶抵抗：何时使用链激酶可能无效？
Br Heart J. 1993 Jul;70(1):97-8. doi: 10.1136/hrt.70.1.97.
3
Coronary thrombolysis and previous SK therapy.
Can J Cardiol. 1993 Jul-Aug;9(6):518-20.
4
Monitoring of streptokinase resistance titre in acute myocardial infarction patients up to 30 months after giving streptokinase or anistreplase and related studies to measure specific antistreptokinase IgG.对急性心肌梗死患者在给予链激酶或阿尼普酶后长达30个月的链激酶抗性滴度进行监测，以及进行相关研究以测定特异性抗链激酶IgG。
Br Heart J. 1992 Aug;68(2):167-70. doi: 10.1136/hrt.68.8.167.
5
Streptokinase neutralisation titres up to 866 days after intravenous streptokinase for acute myocardial infarction.急性心肌梗死静脉注射链激酶后长达866天的链激酶中和效价。
Br Heart J. 1993 Aug;70(2):119-21. doi: 10.1136/hrt.70.2.119.
6
Is the development of antibodies to streptokinase clinically relevant?
Drugs. 1994 Aug;48(2):133-6. doi: 10.2165/00003495-199448020-00001.
7
Do recipients of kidneys from donors treated with streptokinase develop anti-streptokinase antibodies?接受用过链激酶治疗的供体所提供肾脏的受者会产生抗链激酶抗体吗？
Transplant Proc. 2005 Oct;37(8):3272-3. doi: 10.1016/j.transproceed.2005.09.035.
8
Postscript: fibrinolysis after acute myocardial infarction.
Drug Ther Bull. 1991 Feb 18;29(4):16.
9
A latex agglutination assay for the detection of anti-streptokinase antibodies.一种用于检测抗链激酶抗体的乳胶凝集试验。
Biochem Soc Trans. 1998 Feb;26(1):S11. doi: 10.1042/bst026s011.
10
Streptokinase resistance: when might streptokinase administration be ineffective?链激酶抵抗：何时使用链激酶可能无效？
Br Heart J. 1992 Nov;68(5):449-53. doi: 10.1136/hrt.68.11.449.
引用本文的文献
1
Complete Removal of Extracellular IgG Antibodies in a Randomized Dose-Escalation Phase I Study with the Bacterial Enzyme IdeS--A Novel Therapeutic Opportunity.在一项使用细菌酶IdeS的随机剂量递增I期研究中完全清除细胞外IgG抗体——一种新的治疗机会
PLoS One. 2015 Jul 15;10(7):e0132011. doi: 10.1371/journal.pone.0132011. eCollection 2015.
2
A rapid agglutination assay to detect anti-streptokinase antibodies.一种检测抗链激酶抗体的快速凝集试验。
Ir J Med Sci. 2004 Oct-Dec;173(4):204-10. doi: 10.1007/BF02914552.
3
Criteria for drug usage review of thrombolytics in acute myocardial infarction.
Pharmacoeconomics. 1995 Jan;7(1):25-38. doi: 10.2165/00019053-199507010-00004.
4
Are streptokinase antibodies clinically important?链激酶抗体在临床上重要吗？
Br Heart J. 1994 Mar;71(3):303-4. doi: 10.1136/hrt.71.3.303-a.
5
Streptokinase antibodies are of clinical importance and they can be measured in half an hour by a simple enzyme-linked immunosorbent assay.链激酶抗体具有临床重要性，并且可以通过一种简单的酶联免疫吸附测定法在半小时内进行检测。
Br Heart J. 1994 Aug;72(2):209-10. doi: 10.1136/hrt.72.2.209-a.
本文引用的文献
1
Thrombolytic therapy with streptokinase using a standard dosage scheme.采用标准剂量方案的链激酶溶栓治疗。
Br Med J. 1966 Feb 19;1(5485):454-6. doi: 10.1136/bmj.1.5485.454.
2
Safety and efficacy of repeat thrombolytic treatment after acute myocardial infarction.急性心肌梗死后重复溶栓治疗的安全性和有效性。
Br Heart J. 1990 Sep;64(3):177-81. doi: 10.1136/hrt.64.3.177.
3
Antistreptokinase titres after intravenous streptokinase.
Lancet. 1990 Jan 27;335(8683):184-5. doi: 10.1016/0140-6736(90)90276-b.
4
Immunoglobulin response to intravenous streptokinase in acute myocardial infarction.急性心肌梗死患者对静脉注射链激酶的免疫球蛋白反应。
Br Heart J. 1991 Aug;66(2):139-42. doi: 10.1136/hrt.66.2.139.
5
Lack of influence of pretreatment antistreptokinase antibody on efficacy in a multicenter patency comparison of intravenous streptokinase and anistreplase in acute myocardial infarction.
Am Heart J. 1992 Aug;124(2):305-14. doi: 10.1016/0002-8703(92)90591-i.
6
Streptokinase resistance: when might streptokinase administration be ineffective?链激酶抵抗：何时使用链激酶可能无效？
Br Heart J. 1992 Nov;68(5):449-53. doi: 10.1136/hrt.68.11.449.
7
Monitoring of streptokinase resistance titre in acute myocardial infarction patients up to 30 months after giving streptokinase or anistreplase and related studies to measure specific antistreptokinase IgG.对急性心肌梗死患者在给予链激酶或阿尼普酶后长达30个月的链激酶抗性滴度进行监测，以及进行相关研究以测定特异性抗链激酶IgG。
Br Heart J. 1992 Aug;68(2):167-70. doi: 10.1136/hrt.68.8.167.
Zotero 插件